Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CLOBAZAM | 10MG | TABLET | Resolved | 2018-01-17 | 2018-03-03 | 36271 |
| APO-CLOBAZAM | 10MG | TABLET | Resolved | 2018-05-08 | 2018-06-30 | 48838 |
| APO-CLOBAZAM | 10MG | TABLET | Resolved | 2021-11-12 | 2021-12-16 | 149155 |
| APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Resolved | 2019-05-15 | 2019-06-21 | 84122 |
| APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Resolved | 2019-11-20 | 2019-12-19 | 99290 |
| APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Resolved | 2020-06-04 | 2022-09-06 | 116527 |
| APO-CLONAZEPAM | 0.5MG | TABLET | Resolved | 2024-09-20 | 2025-02-14 | 238242 |
| APO-CLONAZEPAM | 2MG | TABLET | Resolved | 2024-11-07 | 2025-02-14 | 242202 |
| APO-CLONAZEPAM | .5MG | TABLET | Resolved | 2017-09-20 | 2018-09-09 | 22870 |
| APO-CLONAZEPAM | .5MG | TABLET | Resolved | 2017-09-21 | 2018-10-05 | 22970 |
| APO-CLONIDINE | 0.025MG | TABLET | Actual shortage | 2017-08-14 | 2017-10-05 | 19136 |
| APO-CLONIDINE TAB 0.1MG | .1MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18994 |
| APO-CLONIDINE TAB 0.2MG | .2MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18997 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2017-05-04 | 2017-07-22 | 8859 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2019-08-14 | 2019-10-15 | 91532 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-09-22 | 2020-12-30 | 124783 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-28 | 2020-12-30 | 127339 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-01-22 | 2021-01-29 | 132349 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2021-04-09 | 2021-04-19 | 137238 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2022-01-21 | 2022-03-17 | 153271 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |